The National Interest

QuSecure Accepted into Forbes Technology Council

Retrieved on: 
Tuesday, November 29, 2022
Networks, Internet, Security, Technology, Software, Dark, The National Interest, Organization, Silicon, CIOS, YEC, Partnership, Education, Government, IPO, Quantum technology, Q&A, Council, Health, Defense, PQC, Department of Defence, Name, Quantum, Publication, Entrepreneurship, Operational technology, Risk management

QuSecure, Inc., a leader in post-quantum cybersecurity (PQC), today announced that Co-Founder and Chief Operating Officer (COO) Skip Sanzeri has been accepted into the Forbes Technology Council, an invitation-only community for world-class CIOs, CTOs, and technology executives.

Key Points: 
  • QuSecure, Inc., a leader in post-quantum cybersecurity (PQC), today announced that Co-Founder and Chief Operating Officer (COO) Skip Sanzeri has been accepted into the Forbes Technology Council, an invitation-only community for world-class CIOs, CTOs, and technology executives.
  • We are honored to welcome Skip into the community, said Scott Gerber, founder of Forbes Councils, the collective that includes the Forbes Technology Council.
  • As an accepted member of the Council, Mr. Sanzeri has access to a variety of exclusive opportunities designed to help him reach peak professional influence.
  • Forbes Councils is a collective of invitation-only communities created in partnership with Forbes and the expert community builders who founded Young Entrepreneur Council (YEC).

DGAP-News: The Navigator Company and P2X-Europe announce a unique Joint Venture in Portugal to produce green, non-fossil synthetic eFuels and scale-up Power-to-Liquid business

Retrieved on: 
Friday, July 22, 2022
Hydrogen, PIN, Carbon, Photosynthesis, SAF, Water, The Navigator Company, Joint venture, Wind, Industry, Power, Tower International, JV, Tree, Microbial contamination of diesel fuel, Electricity, Forest, Carbon cycle, Partnership, Lists of stars, Figueira, News, Green Deal, Policy, Technology, CO2, Ecosystem, Navigator, Project, European Parliament, The National Interest, Engineering, Wax, Electrolysis, The Green Deal, Chemical industry, R group, Renewable energy, Jet fuel, Fine chemical, EU, PTL

The Navigator Company and P2X-Europe announce a unique Joint Venture in Portugal to produce green, non-fossil synthetic eFuels and scale-up Power-to-Liquid business (news with additional features)

Key Points: 
  • The Navigator Company and P2X-Europe announce a unique Joint Venture in Portugal to produce green, non-fossil synthetic eFuels and scale-up Power-to-Liquid business (news with additional features)
    The issuer is solely responsible for the content of this announcement.
  • Furthermore, the quality of the JV builds on Navigators vast industrial operational experience in biorefinery plants and forestry capabilities.
  • Using sustainable forest material in biorefinery industrial processes leads to biogenic CO2 emissions, ensuring a net zero emissions carbon cycle.
  • P2X-Portugals synthetic end-products are a result of a fully sustainable transformation process, initiated with renewable electricity from solar and wind and solar-driven photosynthesis.

DGAP-News: H&R GmbH & Co. KGaA: The Navigator Company and P2X-Europe announce a unique Joint Venture in Portugal to produce green, non-fossil synthetic eFuels and scale-up Power-to-Liquid business

Retrieved on: 
Friday, July 22, 2022
Hydrogen, PIN, Carbon, Photosynthesis, SAF, Water, The Navigator Company, Joint venture, Wind, Industry, Power, JV, Tree, Tower International, Microbial contamination of diesel fuel, Electricity, Forest, Carbon cycle, Partnership, Lists of stars, Figueira, Green Deal, Policy, Technology, CO2, Ecosystem, Navigator, Project, European Parliament, The National Interest, Engineering, Wax, Electrolysis, The Green Deal, Chemical industry, R group, Renewable energy, Jet fuel, Fine chemical, EU, PTL

H&R GmbH & Co. KGaA: The Navigator Company and P2X-Europe announce a unique Joint Venture in Portugal to produce green, non-fossil synthetic eFuels and scale-up Power-to-Liquid business

Key Points: 
  • H&R GmbH & Co. KGaA: The Navigator Company and P2X-Europe announce a unique Joint Venture in Portugal to produce green, non-fossil synthetic eFuels and scale-up Power-to-Liquid business
    The issuer is solely responsible for the content of this announcement.
  • Furthermore, the quality of the JV builds on Navigators vast industrial operational experience in biorefinery plants and forestry capabilities.
  • Using sustainable forest material in biorefinery industrial processes leads to biogenic CO2 emissions, ensuring a net zero emissions carbon cycle.
  • P2X-Portugals synthetic end-products are a result of a fully sustainable transformation process, initiated with renewable electricity from solar and wind and solar-driven photosynthesis.

Ascendant Resources Lagoa Salgada Project Attributed Project of National Interest Status by Portuguese Government

Retrieved on: 
Thursday, April 28, 2022
PEA, Legislation, Tin, Lagoa Salgada, TSX, Lead, Banco Nacional de Investimento, Tax, Disclosure, SEDAR, Economics, Gold, Risk, GLOBE, The National Interest, International trade, Sociedade de Desenvolvimento Mineiro, Growth, PIN, Silver, Company, Toronto Stock Exchange, AICEP, IRR, Zinc, Technical report, News, Investment, Iberian Pyrite Belt, Ascendant, S.A, Government, Copper, Project, Renewable energy, Risk management, Mining, Inference, Sustainability metrics and indices

TORONTO, April 28, 2022 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX: ASND; OTCQB: ASDRF) ("Ascendant" or the "Company) is pleased to announce that the Lagoa Salgada VMS project (the Project) has been recognized by the Portuguese Government as a Project of National Interest (PIN).

Key Points: 
  • TORONTO, April 28, 2022 (GLOBE NEWSWIRE) -- Ascendant Resources Inc. (TSX: ASND; OTCQB: ASDRF) ("Ascendant" or the "Company) is pleased to announce that the Lagoa Salgada VMS project (the Project) has been recognized by the Portuguese Government as a Project of National Interest (PIN).
  • Mark Brennan, Ascendants Executive Chairman commented, To have the Lagoa Salgada project recognized as a Project of National Interest from the Portuguese Government is a very significant milestone for the project.
  • Ascendant holds a 25% interest in the Lagoa Salgada project through its position in Redcorp - Empreendimentos Mineiros, Lda, ("Redcorp") and has an earn-in opportunity to increase its interest in the project to 80%.
  • The Company's interest in the Lagoa Salgada project offers a low-cost entry to a potentially significant exploration and development opportunity, already demonstrating its mineable scale.

MediCane Health Inc. Receives EU GMP License for its manufacturing plant in Portugal

Retrieved on: 
Tuesday, February 15, 2022
Biotechnology, Alternative Medicine, Other Health, Health, Pharmaceutical, Patient, Campo Maior, CEO, GACP, Certification, Medication, Cannabis, Union, Employment, Marketing, Research, The National Interest, MHI, Mediterranean tropical-like cyclone, Industry, Drug, EU

MediCane is the third cannabis company in Portugal to be granted EU-GMP certification.

Key Points: 
  • MediCane is the third cannabis company in Portugal to be granted EU-GMP certification.
  • MediCane will leverage its growing network of distribution and pharma partners in Germany, Portugal, Spain, Poland, and Australia to increase high quality, consistent and reliable supply to patients in need.
  • As a pharmaceutical company, EU-GMP certification cements MediCanes strategy of bridging the gap between pharma and cannabis said Yoav Nir, MediCane Agro CEO.
  • MediCane Health Inc. is an international pharmaceutical company engaged in research and development, as well as the cultivation, production, and marketing of cannabis-based medications.

Harvard Senior Fredericka Lucas First African American to Lead Prestigious Consulting Club

Retrieved on: 
Monday, January 31, 2022
Online, Civic, Leadership development, Welfare, DC, Safety, Disorder, Economics, Baltic Summer Academy, Leadership, Learning, Public policy, Organization, Fredericka Douglass Sprague Perry, Affection, Behavior, Radical behaviorism, African Americans, Human, Mark (given name), Health policy, Efficiency, Research, Housing, Trauma, International relations, Class, The National Interest, Brain, Psychopharmacology, Child, Company, Health, Persuasion, Bain & Company, Thought, Association, Knowledge, Life, Acquisition, Communication, Phillips Academy, Mouse, Harvard University, SAO, Associate, Critical thinking, Computational Statistics & Data Analysis, Management, Medicine, Tutoring, Operation, HCCG, Policy

Fredericka, from Richmond, Virginia, is entering her final semester at Harvard as the first African American elected as Director of the prestigious Harvard College Consulting Group (HCCG).

Key Points: 
  • Fredericka, from Richmond, Virginia, is entering her final semester at Harvard as the first African American elected as Director of the prestigious Harvard College Consulting Group (HCCG).
  • Fredericka has a senior thesis in the works and a full-time job at Bain and Company awaiting her in the fall.
  • Fredericka, pursuing a neuroscience major and economics minor, next applied to Harvard College Consulting Group (HCCG) in the fall of her sophomore year without much knowledge of consulting at all.
  • Last summer, Fredericka interned at Bain & Company, one of the most prestigious consulting firms in the world.

Cantourage launches new dried flower medical cannabis product through partnership with MHI Cultivo Medicinal SA

Retrieved on: 
Thursday, November 4, 2021
Pharmacy, Pesticide, Mediterranean tropical-like cyclone, Research, Cannabis, Radiation, Contract, The National Interest, PIN, Partnership, Patient, Dronabinol, Government, IPM, CEO, Chronic pain, Flower, Humidity, Temperature, MHI, Season, Seizure, Drug, Medicinal plants

BERLIN, Nov. 4, 2021 /PRNewswire/ -- European medical cannabis company Cantourage will from today be making Relecan, a new brand of medical cannabis dried flowers, available in Germany.

Key Points: 
  • BERLIN, Nov. 4, 2021 /PRNewswire/ -- European medical cannabis company Cantourage will from today be making Relecan, a new brand of medical cannabis dried flowers, available in Germany.
  • Cantourage has signed a supply agreement with MHI Cultivo Medicinal, the Portuguese subsidiary of international pharmaceutical company MediCane Health Inc. MHI Cultivo Medicinal grows the flowers in its Alto Alentejo-based greenhouses.
  • Philip Schetter, Co-CEO of Cantourage, said: "Our new partnership with MHI Cultivo Medicinal and the launch of Relecan in Germany represent a significant milestone for the advancement of medical cannabis in Europe.
  • MHI Cultivo Medicinal operates one of the most technologically advanced medical cannabis cultivation facilities in Europe.

New treatment for severe corneal inflammation from DED now listed on PBS

Retrieved on: 
Thursday, September 30, 2021
Narrative, News, Medical Affairs Bureau, TFOS, DED, PBS, Man, Duane syndrome, Optometry, Vaccine, International Regional Science Review, Diagnosis, Food, School, Patient, CSL, Inflammation, Health, S, Journal of Internal Medicine, Keratitis, TGA, Adult, S4, Matilde Leonardi, Classification, Professional services, Immune system, The National Interest, Itchy, Barabino, Current, Woman, Disease, Glass, Impact, Ophthalmology, COVID-19, Pharmaceutical Benefits Scheme, Safety, UNSW, Screen time, Time, George, Eye, Cornea, Pharmaceutical industry, Telescopic sight, Animal, Phosphorus, Health insurance, Medical device

(8,9)

Key Points: 
  • (8,9)
    MELBOURNE, Oct 1, 2021 - (ACN Newswire) - Today, adults living with severe corneal inflammation from DED (dry eye disease) gain access to a new treatment on the PBS.
  • Ikervis(R), Australia's first PBS listed disease-modifying ciclosporin eye drop treatment for severe keratitis in adults with DED, is now available (October 1, 2021).
  • "Artificial tears aim to provide symptom relief for DED, but don't address the underlying cause of severe corneal inflammation.
  • Executive Chair of The B Team Australasia, Lynette has spent the past 16 years living with severe corneal inflammation from DED.